Abbott India Limited (NSE:ABBOTINDIA)
26,000
+180 (0.70%)
Jun 5, 2026, 3:29 PM IST
Abbott India Revenue
In the fiscal year ending March 31, 2026, Abbott India had annual revenue of 69.29B INR with 8.11% growth. Abbott India had revenue of 17.10B in the quarter ending March 31, 2026, with 6.54% growth.
Revenue
69.29B
Revenue Growth
+8.11%
P/S Ratio
7.98
Revenue / Employee
18.94M
Employees
3,659
Market Cap
552.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 69.29B | 5.20B | 8.11% |
| Mar 31, 2025 | 64.09B | 5.60B | 9.58% |
| Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
| Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
| Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 336.53B |
| Zydus Lifesciences | 271.48B |
| Glenmark Pharmaceuticals | 174.43B |
| Alkem Laboratories | 147.12B |
| Mankind Pharma | 142.78B |
| Ipca Laboratories | 98.21B |
| Emcure Pharmaceuticals | 92.04B |
| Laurus Labs | 68.13B |
Abbott India News
- 26 days ago - Abbott India Quarterly report: Q4 2026 - Filings
- 3 months ago - Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36% - Business Upturn
- 4 months ago - Abbott India Quarterly report: Q3 2026 - Filings
- 7 months ago - Abbott India Quarterly report: Q2 2026 - Filings
- 10 months ago - Abbott India Quarterly report: Q1 2026 - Filings
- 1 year ago - Abbott India Annual report: Q4 2025 - Filings
- 1 year ago - Abbott India Quarterly report: Q4 2025 - Filings
- 1 year ago - Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3 - Business Upturn